Abstract
Genomic and proteomic information is transforming all fields of cancer research. The increased understanding of the genomics and molecular pathology of cancer also provides a framework for designing new therapeutic strategies. The majority of the genes in most genomes are still of unknown function, and many studies on proteomics are attempting to fill this knowledge gap. Since biochemical information flows from DNA to RNA to protein to function, the role of each gene product in metabolism clearly needs to be studied. A recent theoretical study by ter Kuile and Westerhoff (2001) using the methods of Metabolic Control Analysis demonstrated that there is no general quantitative relationship between mRNA levels and function. Thus a comprehensive study of many metabolites together could become invaluable, and several approaches to this are being developed including metabolite target analysis, metabolite profiling, metabolomics and metabolic fingerprinting as described elsewhere in this book (Fiehn, Chapter 11, see also Fiehn, 2001).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aboagye EO, Dillehay LE, Bhujwalla ZM, Lee D-J. Hypoxic cell cytotoxin tirapazamine induces acute changes in tumor energy metabolism and pH: a 31P magnetic resonance spectroscopy study. Radiat Oncol Investigat 6: 249–254 (1998).
Chung Y-L, Troy H, Banerji U et al. The pharmacodynamic effects of 17-AAG on HT29 xenografts in mice monitored by magnetic resonance spectroscopy. Proc Am Assoc Cancer Res 43: 73 (2002a).
Chung Y-L, Troy H, Judson IR et al. The effects of CYC202 on tumors monitored by magnetic resonance spectroscopy. Proc Am Assoc Cancer Res 43: 336 (2002b).
Cornish-Bowden A, Cardenas ML. Functional genomics. Silent genes given voice. Nature 409, 571–572 (2001).
Dang CV, Semenza GL. Oncogenic alterations of metabolism. Trends Biochem Sci 24: 68–72 (1999).
Eigenbrodt E, Reinacher M, Scheefer-Borchel U et al. Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells. Crit Rev Oncogenesis 3: 91–115 (1992).
Fiehn O. Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks. Compar Fund Genom 2: 155–168 (2001).
Fiehn O. Metabolomics - the link between genotypes and phenotypes. Plant Mol Biol 48: 155–171 (2002).
Florian CL, Preece NE, Bhakoo KK, Williams SR. Characteristic metabolic profiles revealed by 1H NMR spectroscopy for three types of human brain and nervous system tumors. NMR Biomed 8: 253–264 (1996).
Griffiths JR, Tate AR, Howe FA, Stubbs M. Magnetic resonance spectroscopy of cancer - practicalities of multi-centre trials and early results in non-Hodgkins lymphoma. Eur J Cancer 38: in press (2002a).
Griffiths JR, McSheehy PMJ, Robinson SP et al. Metabolic changes detected by in vivo magnetic resonance studies of HEPA-1 wild-type tumor deficient in hypoxia-inducible factor-1β (HIF-1β): evidence of an anabolic role for the HIF-1 pathway. Cancer Res 62: 688–695 (2002b).
Griffiths JR, Stubbs M. Opportunities for studying cancer by metabolomics: preliminary observations on tumors deficient in hypoxia-inducible factor 1. Adv Enzyme Reg in press (2003).
Leach MO, Verrill M, Glaholm J et al. Measurements of human breast cancer using magnetic resonance spectroscopy: a review of clinical measurements and a report of localized 31P measurements of response to treatment. NMR Biomed 11: 314–340 (1998).
Maxwell PH, Dachs GU, Gleadle JM etal. Hypoxia-inducible factor 1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci USA 94: 8104–8109 (1997).
McSheehy PMJ, Robinson SP, Ojugo ASE etal. Carbogen breathing increases 5-fluorouracil uptake and cytotoxicity in hypoxic murine RIF-1 tumors: a magnetic resonance study in vivo. Cancer Res 58: 1185–1194 (1998).
Raamsdonk LM, Teusink B, Broadhurst D et al. A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nature Biotechnol 19: 45–50 (2001).
Ronen SM, DiStefano F, McCoy CL et al. Magnetic resonance detects metabolic changes associated with chemotherapy-induced apoptosis. Br J Cancer 80: 1035–1041 (1999).
Snell K, Fell DA. Metabolic control analysis of mammalian serine metabolism. Adv Enzyme Reg 30: 13–32 (1989).
Stratford IJ, Patterson AV, Dachs GU et al. Hypoxia-mediated gene expression. In Tumor Hypoxia. Vaupel P, Kelleher DK (Ed) pp. 107–113, Wissenschaftliche Verlagsgesellschaft, Stuttgart (1999).
Stubbs M, Griffiths JR. Monitoring cancer by magnetic resonance. Br J Cancer 80: 86–94 (1999).
ter Kuile BH, Westerhoff HV. Transcriptome meets metabolome: hierarchical and metabolic regulation of the glycolytic pathway. FEBS Lett 500: 169–171 (2001).
Tate AR, Griffiths JR, Martinez-Perez I et al. Towards a method for automated classification of 1H MRS spectra from brain tumors. NMR Biomed 11: 177–191 (1998).
Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop- PAS heterodimer regulated by cellular 02 tension. Proc Natl Acad Sci USA 92: 5510–5514 (1995).
Williams KJ, Telfer BA, Airley RA et al. A protective role for HIF-1 in response to redox manipulation and glucose deprivation: implications for tumorigenesis. Oncogene 21: 282–290 (2002).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Chung, YL., Stubbs, M., Griffiths, J.R. (2003). Metabolic Profiling in Tumors by In Vivo and In Vitro NMR Spectroscopy. In: Harrigan, G.G., Goodacre, R. (eds) Metabolic Profiling: Its Role in Biomarker Discovery and Gene Function Analysis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0333-0_5
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0333-0_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5025-5
Online ISBN: 978-1-4615-0333-0
eBook Packages: Springer Book Archive